FLX Bio's Series B Round

FLX Bio raised a round of funding on April 27, 2016.

FLX Bio is a biotechnology company focused on the creation, development and commercialization of novel anti-cancer therapeutics. Toward this end, the company is leveraging unexploited insights in immu…

Articles about FLX Bio's Series B Round: